NDC 51672-4083-01 - Hydrocortisone Butyrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4083
- Requested NDC
- 51672-4083-01
- Package NDCs from labels
- 51672-4083-5, 51672-4083-7, 51672-4083-1, 51672-4083-2, 51672-4083-6, 51672-4083-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocortisone Butyrate Ointment, 0.1% Hydrocortisone Butyrate Cream USP, 0.1% Hydrocortisone Butyrate Topical Solution, 0.1% | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4083-1 | Hydrocortisone Butyrate | 15 g in 1 TUBE | OINTMENT | 15 | 5 | |
| 51672-4083-1 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-2 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-2 | Hydrocortisone Butyrate | 30 g in 1 TUBE | OINTMENT | 30 | 5 | |
| 51672-4083-5 | Hydrocortisone Butyrate | 5 g in 1 TUBE | OINTMENT | 5 | 5 | |
| 51672-4083-6 | Hydrocortisone Butyrate | 45 g in 1 TUBE | OINTMENT | 45 | 5 | |
| 51672-4083-6 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-7 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-7 | Hydrocortisone Butyrate | 10 g in 1 TUBE | OINTMENT | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4083 | HYDROCORTISONE BUTYRATE SOLUTION HYDROCORTISONE BUTYRATE CREAM HYDROCORTISONE BUTYRATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 9 package rows | 20210409_51176835-598d-4da7-8a00-6bd36f52aa82.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4083-1 | GM - Gram | 51672-4083 | efb8d4d9-57f2-4954-890a-9738be50e6ed | 1 | 2012-07-24 |
| 51672-4083-6 | GM - Gram | 51672-4083 | 146e42f8-c9cd-4fa2-b41a-089bcca3cb99 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Petroleum Jelly | WHITE PETROLATUM | WAL-MART STORES INC | 00faa772-53f3-9276-e063-6394a90a2dab | 2026-04-07 | Warnings | 4T6H12BN9U |
| 70% | ISOPROPYL ALCOHOL | Perrigo Direct, Inc | f953a249-07ad-40a1-8aea-b2d419fd3d4d | 2026-04-07 | Warnings, Adverse reactions | ND2M416302 |
| Thera Plus Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | Fourstar Group USA, Inc. | 5d63bf97-29d2-4c71-97c3-85f425e86207 | 2026-04-07 | Warnings | PDC6A3C0OX |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC | 58c24504-47de-487a-ab8d-18add155ea95 | 2026-04-07 | Adverse reactions | 2968PHW8QP |
| Petroleum | WHITE PETROLATUM | CVS Pharmacy, Inc. | 4dc08832-e610-4e62-a6af-cadaa339e39e | 2026-04-06 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | Amazon.com Services LLC | 616ef87d-1518-46aa-8e12-9a1b678d4980 | 2026-04-06 | Warnings, Adverse reactions | 4T6H12BN9U |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | WinCo Foods, LLC | c22a5fc3-78f5-4660-96a6-479ca6f77602 | 2026-04-06 | Warnings, Adverse reactions | ND2M416302 |
| 70% Isopropyl Rubbing Alcohol | ISOPROPYL RUBBING ALCOHOL | WinCo Foods, LLC | 2b48ee19-8f0c-4b36-855d-7909dde5c871 | 2026-04-06 | Warnings, Adverse reactions | ND2M416302 |
| 50% Rubbing | ISOPROPYL ALCOHOL | Perrigo Direct, Inc | 698bede7-4fc1-4e85-8ac4-d735f409cfae | 2026-04-06 | Warnings, Adverse reactions | ND2M416302 |
| Jack Black | AVOBENZONE/HOMOSALATE/OCTISALATE/PETROLATUM | Jack Black L.L.C. | 4baade5c-e759-d98f-e063-6394a90aa056 | 2026-04-03 | Warnings | 4T6H12BN9U |
| KIDS TOOTHPASTE, FOR CAVITY PROTECTION | KIDS TOOTHPASTE FOR CAVITY PROTECTION | Shulisa (Foshan) Daily ChemicalIndustry Co., Ltd | 4e8fab9e-f05c-5e2f-e063-6294a90aecf9 | 2026-04-03 | Warnings | 059QF0KO0R |
| Medt Pad | ISOPROPYL ALCOHOL | Carelife (USA) Inc. | 74a05c37-becd-4c93-96cb-79f69add5e4d | 2026-04-02 | Warnings | ND2M416302 |
| Walgreens Swimmers Ear | ISOPROPYL ALCOHOL | Walgreens Co | 3fb65a5c-c47f-ef2b-e063-6394a90af21a | 2026-04-01 | Warnings | ND2M416302 |
| Isopro First Aid | ISOPROPYL ALCOHOL | Water-Jel Technologies | f38563f5-ee54-4979-9157-4bf8fd60daab | 2026-03-31 | Warnings | ND2M416302 |
| Critic-Aid Clear | PETROLATUM | Coloplast Corp | a92c18f7-52b2-43e4-bae3-2bab9de22671 | 2026-03-31 | Warnings | 4T6H12BN9U |
| Redness Relief | GLYCERIN, NAPHAZOLINE HCL | Pharmadel LLC | 4c113bb9-814f-d92d-e063-6294a90a8302 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Verifine Alcohol Swabs | ALCOHOL SWABS | Promisemed Hangzhou Meditech Co.,LTD. | 4e404989-89d0-b189-e063-6394a90a8caa | 2026-03-30 | Warnings | ND2M416302 |
| MedPride Sterile Prep Pads | ISOPROPYL ALCOHOL | Shield Line LLC | 31de24d8-b70e-47f1-8946-6bd9fb16b5d5 | 2026-03-30 | Warnings | ND2M416302 |
| Hemorrhoidal | LIDOCAINE, MINERAL OIL, PHENYLEPHRINE HCL, WHITE PETROLATUM | Walgreens Co | 3d213ba8-3cbe-11c4-e063-6394a90ae016 | 2026-03-30 | Warnings | T5L8T28FGP |
| Moisture Oyster | GLYCERIN | Moisture Oyster Inc | 4e45317a-437f-4d88-e063-6294a90a98d0 | 2026-03-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.